Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hello Alpha vs Tablet Health

Hello Alpha
Graded #354

Higher grade

vs+11.299999999999997
Tablet Health
Graded #495

Lower grade

The verdict

Hello Alpha takes it — 58.9/100 to 47.6/100.

Hello Alpha grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Hello Alpha (formerly Alpha Medical) is a US telehealth platform offering a full weight-loss lineup: branded GLP-1s including Wegovy, Ozempic, Rybelsus, Zepbound and Mounjaro, plus the oral GLP-1 Foundayo…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationHello Alpha +13
64
51
Clinical oversightHello Alpha +40
77
37
Labs & monitoringHello Alpha +4
54
50
FulfillmentHello Alpha +10
67
57
Contract termsTablet Health +14
41
55
Hello Alpha · left barTablet Health · right bar

The numbers

MetricHello AlphaTablet Health
WeighScore58.9/10047.6/100
GradeCC
Scorecard rank#354#495
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesYes
Hello Alpha

Graded #354 · C

Strengths

  • Full branded GLP-1 lineup: Wegovy, Ozempic, Rybelsus, Zepbound, Mounjaro
  • Offers the oral GLP-1 Foundayo plus oral weight-loss medications
  • Works with insurance
  • Ongoing clinician care via online membership

Where it loses points

  • Cash pricing is not published on the public site
  • Full state list is not enumerated
  • Insurance coverage of the medication still depends on your plan
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard